Vaxcyte Inc. (PCVX)
NASDAQ
63.68
+0.06 (+0.09%)
Closed
Oct 19, 2026
Day's Range
63.3866.02
52 wk Range
39.8790.75
Financial Statements - PCVX - Vaxcyte Inc.
Revenue
0
Net Income
-766.62M▼ 65.2%
EBITDA
-898.81M▼ 100.6%
Free Cash Flow
-712.55M▼ 24.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -923.67M | -569.54M | -388.27M | -207.33M | -102.08M | -87.10M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 37.32M | -4.37M | -76.89M | -24.50M | 1.67M | -2.35M |
| Pre Tax Income | -766.62M | -463.92M | -402.26M | -223.48M | -100.07M | -89.21M |
| Income Tax | - | - | - | - | - | - |
| Net Income | -766.62M | -463.92M | -402.26M | -223.48M | -100.07M | -89.21M |
| EPS Basic | -5.63 | -3.8 | -4.14 | -3.44 | -1.93 | -3.02 |
| EPS Diluted | -5.63 | -3.8 | -4.14 | -3.44 | -1.93 | -3.02 |
| Basic Shares Outstanding | 136.08M | 121.99M | 97.15M | 64.87M | 51.92M | 29.54M |
| Diluted Shares Outstanding | 136.08M | 121.99M | 97.15M | 64.87M | 51.92M | 29.54M |
| Ebit | -923.67M | -463.92M | -402.26M | -223.48M | -100.07M | -89.21M |
| Ebitda | -898.81M | -448.08M | -315.19M | -189.77M | -98.28M | -85.45M |
| Net Income Continuous Operations | -766.62M | -463.92M | -402.26M | -223.48M | -100.07M | -89.21M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
